# Pipemidic Acid

## Dolcol 250mg

| TAH Drug Code      | [ODOLC](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ODOLC)                                                                                                                                                                                                                                          |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | UTI, Bacillary dysentery, enteritis, otitis media and sinusitis                                                                                                                                                                                                                                                 |
| Dosing             | Adult: 500-2000 mg/day, divided Q6-8H. For adults with pyelonephritis, pyelitis, cystitis, urethritis, and prostatitis: 2-8 tablets (500-2000mg) daily, divided into 3-4 doses. For adults with otitis media, sinusitis, enteritis, and bacterial dysentery: 6-8 tablets (1500-2000mg), divided into 3-4 doses. |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                   |
| Renal Impairment   | Dose adjustment required                                                                                                                                                                                                                                                                                        |
| Contraindications  | Hypersensitivity to any component of the formulation.                                                                                                                                                                                                                                                           |
| Adverse Effects    | GI symptoms. CNS, skin reactions. Muscular weakness, myalgia. CI: Hypersensitivity, children, pregnancy and lactation. infants < 3 months.                                                                                                                                                                      |
| Pregnancy          | Unknown                                                                                                                                                                                                                                                                                                         |
| Lactation          | Unknown                                                                                                                                                                                                                                                                                                         |

